Winnow Wealth LLC Purchases Shares of 461 Procter & Gamble Company (The) $PG

Winnow Wealth LLC bought a new stake in shares of Procter & Gamble Company (The) (NYSE:PG) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 461 shares of the company’s stock, valued at approximately $73,000.

A number of other hedge funds have also recently modified their holdings of PG. Vanguard Group Inc. grew its stake in shares of Procter & Gamble by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after acquiring an additional 3,189,111 shares during the period. Kingstone Capital Partners Texas LLC boosted its holdings in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Geode Capital Management LLC increased its stake in Procter & Gamble by 1.8% in the 2nd quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company’s stock worth $9,439,341,000 after buying an additional 1,060,713 shares in the last quarter. Northern Trust Corp raised its holdings in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after acquiring an additional 248,792 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $146.79 on Thursday. The stock has a market cap of $343.00 billion, a price-to-earnings ratio of 21.44, a price-to-earnings-growth ratio of 3.87 and a beta of 0.36. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The stock has a 50 day moving average price of $151.10 and a 200-day moving average price of $156.27. Procter & Gamble Company has a one year low of $144.09 and a one year high of $180.43.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. During the same period last year, the company earned $1.93 earnings per share. Procter & Gamble’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s payout ratio is currently 61.61%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. UBS Group lowered their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Raymond James Financial cut their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. JPMorgan Chase & Co. boosted their target price on Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. BNP Paribas restated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Finally, Morgan Stanley set a $175.00 target price on Procter & Gamble in a research report on Monday, October 27th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $171.53.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the sale, the chief executive officer owned 61,764 shares of the company’s stock, valued at $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 11,684 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $1,778,655.32. Following the transaction, the chief executive officer owned 319,932 shares of the company’s stock, valued at $48,703,248.36. This trade represents a 3.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 31,308 shares of company stock worth $4,768,692 in the last three months. 0.20% of the stock is owned by insiders.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.